Effect of exogenous dsRNA on expression of p21 in renal clear cell carcinoma cells

Abstract

Abstract:ObjectiveTo investigate the effect of dsP21555 transfection on the expression of tumor suppressor gene p21 in renal clear cell carcinoma cell lines ACHN and 786O. MethodsRenal clear cell carcinoma cells were transfected with dsControl and dsP21555 with Lipofectamine 3000 respectively. Realtime quantitative PCR (RTqPCR) and Western blotting were used to detect the expression of p21 mRNA and protein. Cell cycle distribution was detected by flow cytometry (FCM). Cell viability and proliferation were analyzed by cell viability assay (MTS method) and colony culture assay. ResultsIn ACHN and 786O cells, the expressions of p21 mRNA in dsP21555 group (2.86±0.33, 1.96±0.35) were significantly higher than those in dsControl group (1.05±0.34, 1.01±0.14), which were increased to 2.72 times (t=7.640, P<0.001) and 1.95 times (t=5.058, P=0.002). Western blotting showed that the expressions of P21 protein were upregulated in both renal cell lines, which was consistent with p21 mRNA upregulation. The result of FCM showed that the cell cycle was blocked in G0G1 phase (57.08%±5.66% vs. 46.06%±4.60%, t=3.023, P=0.023; 61.58%±6.23% vs. 42.25%±6.08%, t=4.444, P=0.004) after transfection of dsP21555 in renal clear cell carcinoma cells. MTS result showed that the vitality of both cell lines after transfection of dsP21555 decreased compared with dsControl group， their absorbance values were 0.85±0.20 vs.1.27±0.13, t=3.410, P=0.014; 1.04±0.25 vs.1.55±0.10, t=3.758, P=0.009. Colony culture experiments showed that the numbers of colonies formed by ACHN and 786O in the dsControl group were 110.91±26.21 and 129.99±22.87 respectively, and the numbers of colonies formed in the dsP21555 group were 59.37±14.23 (t=3.456, P=0.014) and 71.26±21.38 (t=3.745, P=0.010), indicating that the proliferation of cells in the dsP21555 group was significantly reduced. ConclusiondsP21555 can upregulate the expression of p21 gene in renal clear cell carcinoma cells and inhibit the growth of carcinoma cells, suggesting that dsP21555 may become a new gene therapy tool.

Key words:Kidney neoplasms,Oncogene protein p21 (ras),Cell proliferation,dsP21-555

Huang Geng, Jiang Weidong, Mao Qing, Gui Dingwen. Effect of exogenous dsRNA on expression of p21 in renal clear cell carcinoma cells[J]. Journal of International Oncology, 2017, 44(7): 481-484.

References

［1］ Liang T, Hu XY, Li YH, et al. MicroRNA-21 regulates the proliferation, differentiation, and apoptosis of human renal cell carcinoma cells by the mTORSTAT3 signaling pathway［J］. Oncol Res, 2016, 24(5): 371-380. DOI: 10.3727/096504016X14685034103356. ［2］ De Meerleer G, Khoo V, Escudier B, et al. Radiotherapy for renalcell carcinoma［J］. Lancet Oncol, 2014, 15(4): e170e177. DOI: 10.1016/S14702045(13)705692. ［3］ Ge Q, Wang C, Chen Z, et al. Effect of synthetic small doublestranded RNA on the development of bladder cancer by activating P21 expression［J］. Zhonghua Yi Xue Za Zhi, 2016, 96(10):812-816. DOI: 10.3760/cma.j.issn.0376-2491.2016.10.013. ［4］ Hu J, Chen Z, Xia D, et al. Promoterassociated small doublestranded RNA interacts with heterogeneous nuclear ribonucleoprotein A2/B1 to induce transcriptional activation［J］. Biochem J, 2012, 447(3): 407-416. DOI: 10.1042/BJ20120256. ［5］ Jiao AL, Slack FJ. RNAmediated gene activation［J］. Epigenetics, 2014, 9(1): 27-36. DOI: 10.4161/epi.26942. ［6］ Guo D, Barry L, Lin SS, et al. RNAa in action: from the exception to the norm［J］. RNA Biol, 2014, 11(10): 1221-1225. DOI: 10.4161/15476286.2014.972853. ［7］ Pan SL, Yu YY. Small noncoding RNA and RNA activation［J］. Zhonghua Bing Li Xue Za Zhi, 2013, 42(4): 280-282. DOI: 10.3760/cma.j.issn.05295807.2013.04.019. ［8］ Kosaka M, Kang MR, Yang G, et al. Targeted p21WAF1/CIP1 activation by RNAa inhibits hepatocellular carcinoma cells［J］. Nucleic Acid Ther, 2012, 22(5): 335-343. DOI: 10.1089/nat.2012.0354. ［9］ Karimian A, Ahmadi Y, Yousefi B. Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage［J］. DNA Repair (Amst), 2016, 42: 63-71. DOI: 10.1016/j.dnarep.2016.04.008. ［10］ Wang C, Tang K, Li Z, et al. Targeted p21(WAF1/CIP1) activation by miR1236 inhibits cell proliferation and correlates with favorable survival in renal cell carcinoma［J］. Urol Oncol, 2016, 34(2): 59.e23-59.e34. DOI: 10.1016/j.urolonc.2015.08.014.

[1]	Ren Lu, Xie Xiaoli, Zhang Kun, Wang Lijuan.Effects and mechanisms of dihydroartemisinin combined with carfilzomib on the activity， proliferation， and apoptosis of multiple myeloma cells[J]. Journal of International Oncology, 2024, 51(3): 129-136.
[2]	Xiang Yuling, Tan Jiajie, Xiong Yuanguo, Zhao Lirong, Li Chen, Zhang Hong.Effects of Anhydroicaritin on the proliferation， migration and apoptosis of hepatocellular carcinoma cells[J]. Journal of International Oncology, 2023, 50(9): 513-519.
[3]	Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin.lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway[J]. Journal of International Oncology, 2023, 50(4): 202-207.
[4]	Qian Weiwei, Xu Shen, Kong Qi.Differential diagnosis value of D-dimer before operation in renal oncocytoma and chromophobe renal cell carcinoma[J]. Journal of International Oncology, 2023, 50(10): 614-617.
[5]	Lian Haiwei, Yang Shuorui, Liu Renzhong.Mechanism study on regulation of glioblastoma cell proliferation and apoptosis by sciadopitysin combined with CX-4945 through Notch1 pathway[J]. Journal of International Oncology, 2022, 49(6): 321-326.
[6]	Zhou Renbang, Zhang Zhongchuan, Xu Zhiyuan, Zhu Xunbing.MiR-219a-5p inhibits the proliferation, invasion and migration of osteosarcoma U2OS cells by negatively regulating HMGA2[J]. Journal of International Oncology, 2022, 49(4): 193-198.
[7]	Laibijiang Wusiman, Cao Bowei, Zhang Wenbin, Gao Hua.Effects of exogenous AGR2 on the proliferation and invasion abilities of colon cancer cells[J]. Journal of International Oncology, 2022, 49(2): 73-78.
[8]	Zhang Yongli, Zhang Ruojia, Fan Huancai, Ge Luna, Wang Lin.TXNDC5-Prx2 axis regulates drug resistance of prostate cancer cells[J]. Journal of International Oncology, 2021, 48(8): 473-478.
[9]	Jiang Mengting, Wang Jiachun, Zong Jing.Effects of NFAT5 inhibition on proliferation, invasion, migration and apoptosis of lung adenocarcinoma cells[J]. Journal of International Oncology, 2021, 48(6): 321-327.
[10]	Yan Xingyu, Lian Zhenying, Diao Yutao, Liu Hongyan.BMXΔN mediates gefitinib resistance of lung cancer cells through ERK/MAPK signaling pathway[J]. Journal of International Oncology, 2021, 48(6): 328-334.
[11]	Ma Xiuzhen, Lu Yan, Zhao Bingbing, Qiu Hongcong, Xu Xun, Wei Min.Effects of total flavonoids from Baeckea frutescens on the migration, invasion and apoptosis of cervical cancer SiHa cells[J]. Journal of International Oncology, 2021, 48(4): 206-211.
[12]	Xiong Lin, Zhang Xiuyun, Zhang Xiaoyu, Li Yue, Xu Ximing.IWR-1-endo affects the migration and proliferation of hepatocarcinoma cells by inhibiting the Wnt pathway[J]. Journal of International Oncology, 2021, 48(12): 711-715.
[13]	Li Zhefeng, Li Jie, Zhao Xiaoting, Yue Wentao.GLDC regulates proliferation and apoptosis of ovarian cancer cells through PI3K/Akt/mTOR pathway[J]. Journal of International Oncology, 2021, 48(12): 716-722.
[14]	Wu Guang, Yu Yuandong, Chen Ping.Clinical observation of apatinib mesylate in the treatment of metastatic renal carcinoma[J]. Journal of International Oncology, 2021, 48(11): 655-659.
[15]	Zhong Yang, He Miao, Liu Zhi, Chen Jianyu, Zhang Guangnian, Qin Long, Li Ting, Li Jianshui.Effects of Ophiopogon D combined with cyclooxygenase-2 silencing on proliferation, migration and invasion of human pancreatic cancer BxPC-3 cells[J]. Journal of International Oncology, 2021, 48(10): 583-590.